Oppenheimer Asset Management Inc. Elanco Animal Health Inc Transaction History
Oppenheimer Asset Management Inc.
- $6.65 Billion
- Q1 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 12,100 shares of ELAN stock, worth $169,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,100Holding current value
$169,521% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ELAN
# of Institutions
407Shares Held
473MCall Options Held
2.6MPut Options Held
916K-
Dodge & Cox San Francisco, CA83.8MShares$1.17 Billion0.84% of portfolio
-
Primecap Management CO Pasadena, CA52.9MShares$741 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.3MShares$690 Million0.02% of portfolio
-
Black Rock Inc. New York, NY26.6MShares$373 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD22.1MShares$310 Million0.04% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.64B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...